{
    "article_link": "https://www.frontiersin.org/articles/10.3389/fcell.2021.649265/full",
    "data": [
        {
            "id": "data_1",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163574",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE163574"
        },
        {
            "id": "data_2",
            "omics": "Proteomics",
            "link": "https://www.ebi.ac.uk/pride/archive/projects/PXD023344",
            "format": "raw",
            "source": "ProteomeXchange",
            "public_id": "PXD023344"
        },
        {
            "id": "data_3",
            "omics": "Phosphoproteomics",
            "link": "https://www.ebi.ac.uk/pride/archive/projects/PXD023345",
            "format": "raw",
            "source": "ProteomeXchange",
            "public_id": "PXD023345"
        },
        {
            "id": "data_4",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62452",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE62452"
        },
        {
            "id": "data_5",
            "omics": "Transcriptomics",
            "link": "https://dcc.icgc.org/datasets",
            "format": "",
            "source": "International Cancer Genome Consortium (ICGC)",
            "public_id": "AU"
        },
        {
            "id": "data_6",
            "omics": "Transcriptomics",
            "link": "https://portal.gdc.cancer.gov/projects/TCGA-PAAD",
            "format": "",
            "source": "The Cancer Genome Atlas (TCGA)",
            "public_id": "TCGA_PAAD"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Transcriptomics",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "Treatment": [
                    "anlotinib",
                    "DMSO"
                ]
            }
        },
        {
            "id": "analysis_2",
            "analysis_name": "Differential analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "Fold change": [
                    ">=2"
                ],
                "FDR": [
                    "<0.05"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Ingenuity Pathway Analysis (IPA)",
            "analysis_data": [
                "analysis_2"
            ],
            "label": null
        },
        {
            "id": "analysis_4",
            "analysis_name": "Label-free quantitative proteomics",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "Fold change": [
                    ">1.2"
                ],
                "p-value": [
                    "<0.05"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "Phosphoproteomics",
            "analysis_data": [
                "data_3"
            ],
            "label": {
                "Fold change": [
                    ">1.2"
                ],
                "p-value": [
                    "<0.05"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Integrated analysis",
            "analysis_data": [
                "analysis_2",
                "analysis_4",
                "analysis_5"
            ],
            "label": null
        },
        {
            "id": "analysis_7",
            "analysis_name": "Classification analysis",
            "analysis_data": [
                "analysis_6"
            ],
            "label": {
                "Risk score": [
                    "high",
                    "low"
                ]
            }
        },
        {
            "id": "analysis_8",
            "analysis_name": "Regression analysis",
            "analysis_data": [
                "analysis_7"
            ],
            "label": null
        },
        {
            "id": "analysis_9",
            "analysis_name": "Gene signature analysis",
            "analysis_data": [
                "analysis_2",
                "data_4",
                "data_5",
                "data_6"
            ],
            "label": {
                "Risk score": [
                    "high",
                    "low"
                ]
            }
        },
        {
            "id": "analysis_10",
            "analysis_name": "LASSO Cox Regression",
            "analysis_data": [
                "analysis_2",
                "data_4",
                "data_5",
                "data_6"
            ],
            "label": null
        },
        {
            "id": "analysis_11",
            "analysis_name": "Multivariate Cox Regression",
            "analysis_data": [
                "analysis_10"
            ],
            "label": null
        },
        {
            "id": "analysis_12",
            "analysis_name": "Gene Set Enrichment Analysis (GSEA)",
            "analysis_data": [
                "analysis_9"
            ],
            "label": {
                "Risk score": [
                    "high",
                    "low"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "IC50",
            "value": "5.535 μM (PANC-1); 4.642 μM (AsPC-1)",
            "features": null
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Number of DEGs",
            "value": "992",
            "features": null
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "Enriched pathways",
            "value": "24 cancer-related canonical pathways",
            "features": [
                "Unfolded protein response",
                "Cell cycle: G2/M DNA damage checkpoint regulation",
                "p53 signaling pathway"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Number of differentially expressed proteins",
            "value": "1046",
            "features": [
                "Ribosome",
                "Lysosome"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Number of differentially phosphorylated peptides",
            "value": "4323",
            "features": [
                "Cell cycle",
                "RNA transport",
                "Spliceosome"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "Shared mechanisms",
            "value": "Post-transcriptional regulation of ribosome and lysosome",
            "features": [
                "Ribosome biogenesis",
                "Lysosomal function"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "Proportion in high-risk group",
            "value": "57%",
            "features": [
                "TCGA_PAAD",
                "GSE62452",
                "ICGC_AU"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "Hazard Ratio (HR)",
            "value": "2.318 (risk score); 1.831 (N stage)",
            "features": [
                "Independent prognostic factors"
            ]
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "AUC",
            "value": "0.7 (3 years); 0.72 (5 years) in TCGA_PAAD; 0.87 (3 years); 0.85 (5 years) in GSE62452; 0.65 (3 years); 0.75 (5 years) in ICGC_AU",
            "features": [
                "TOP2A",
                "CRABP2",
                "CDK1",
                "NUSAP1",
                "PERP"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "Selected genes",
            "value": "5 genes: TOP2A, CRABP2, CDK1, NUSAP1, PERP",
            "features": null
        },
        {
            "analysis_id": "analysis_11",
            "metrics": "Hazard Ratio (HR)",
            "value": "2.318 (risk score); 1.831 (N stage)",
            "features": [
                "Independent prognostic factors"
            ]
        },
        {
            "analysis_id": "analysis_12",
            "metrics": "Enriched pathways",
            "value": "33 pathways significantly enriched in high-risk subgroup",
            "features": [
                "Nucleotide excision repair",
                "Mismatch repair",
                "Homologous recombination",
                "Base excision repair",
                "Cell cycle",
                "p53 signaling pathway",
                "DNA replication",
                "Oocyte meiosis",
                "Spliceosome",
                "RNA degradation",
                "Aminoacyl tRNA biosynthesis",
                "Pancreatic cancer",
                "Small cell lung cancer"
            ]
        }
    ]
}